25-01-2021
Panel1
Labelled amount
µg/cm
2
1. Nickelsulphate 200
2.Woolalcohols 1000
3. Neomycin sulphate 230
4. Potassiumdichromate 23
5. Caine mixa) 630
6. Fragrancemixb) 430
7. Colophony 850
8. Epoxyresin 50
9. Quinoline mixc) 190
10. BalsamofPeru 800
11. Ethylenediamine dihydrochloride 50
12. Cobalt chloride 20
Panel2
13. p-tert Butylphenol 50
formaldehyde resin
14. Paraben mixd) 1000
15. Carbamixe) 250
16. Blackrubbermixf) 75
17. Cl+Me-Isothiazolinone 4
(Kathon CG)
18. Quaternium-15 100
19. Mercaptobenzothiazole 75
20. p-Phenylenediamine 90
21. Formaldehyde g) 180
22. Mercaptomixh) 75
23. Thiomersal 8
24. Thiurammixi) 25
a) Five partsofbenzocaine, one part of
cinchocaine hydrochlorideandamethocaine
hydrochloride.
b) Five partsofgeraniolandoakmoss,
four partsofhydroxycitronellaland
cinnamylalcohol, two partsofcinnamaldehyde
and eugenoland one part of
isoeugenolandamylcinnamaldehyde.
c)Equalweightsofclioquinoland
chlorquinaldol.
d) Equalweightsofmethylparahydroxybenzoate,
ethylparahydroxybenzoate,
propylparahydroxybenzoate, butyl
parahydroxybenzoateandbenzyl
parahydroxybenzoate.
e) Equalweightsofdiphenylguanidine,
zincdiethyldithiocarbamate and
zincdibutyldithiocarbamate.
f)Two partsofN-isopropyl- N’-phenyl
paraphenylenediamine, five partsofNcyclohexyl-
N’-phenylparaphenylenediamine
andfive partsofN,N’-diphenyl
paraphenylenediamine.
g) ActuallycontainsN-hydroxymethylsuccinimide.
h) Equalweightsofmorpholinylmercaptobenzothiazole,
N-cyclohexylbenzothiazyl
sulphenamide and dibenzothiazyl
disulphide.
i)Equalweightsofdisulfiram, dipentamethylenethiuram
disulphide, tetramethylthiuram
disulphide and tetramethylthiuram
monosulphide.
Excipients:Sodiumcarbonate, Sodium
bicarbonate,Polyvidone90,Hydroxypropyl
cellulose, Methylcellulose,ß-Cyclodextrin.
DESCRIPTION
TRUETest
TM isa ready-to-use patch test
indicatedfor the diagnosisof allergiccontact
dermatitis. It consistsof24 ofthemost
common allergens/allergen mixes.
The test consistsof2 piecesofsurgicaltape
with 24polyester patcheswhich are coated
with afilmcontaining aspecificallergen or
allergen mix.
Due totheinstabilityofsome allergenson
panel2, adesiccant paper hasbeen included
in thepouch. Thisisto assure stability
throughout theshelf-life.
CLINICALPHARMACOLOGY
Apositive response tothe patch test isa
classicaldelayed hypersensitivityreaction
(type IV), which can appearwithin 6-96
hoursafter exposure.
The cell-mediatedresponse involvesthe
Langerhans’cellandT-lymphocyteswhich
interact andproduce lymphokines. These
lymphokinesthenformlymphocyte clones
which trigger macrophagesto cause acutaneous
inflammation. (1)
Clinicalsignsofa positive allergiccontact
dermatitisreaction are: erythema, oedema,
papules, vesiclesanda palpable dermal
inflammatoryinfiltration at the test area.
INDICATIONSAND USAGE
TRUETest
TM isindicatedprimarilyfor the
diagnosisofallergiccontactdermatitisin
patientswhose historysuggestssensitization
to one or more ofthe substancesin the
test panel.
To excludesensitization asapossible aetiology,
TRUETest
TM mayalso beused
adjunctivelyto evaluateothereczemas
(atopicseborrhoeic, venous, palmar and
plantarhyperkeratoticeczema, vesiculosis
or neurodermatitis)andotherdermatological
diseases, such asleg ulcersandpsoriasis
that do not heal.
Aclinicalhistorythatsuggestsa contact
allergyshould beconfirmed with apatch
test. (2)
CONTRAINDICATIONS
The limited amountofallergen on each
TRUETest
TM patch which penetratesthe
skin willrarelyinduce aflare-up ofdermatitis.
In the case ofextensive ongoing contact
dermatitis,however, thetest should not be
applied since it mayprovokean intensified
reaction on both the present and previously
affectedsitesandmayalso cause a falsepositive
test result.
WARNINGS
Occasionallysensitization toa substance
on the test panelmayoccurwhen patch
testing.
Atest reaction that appearslater than 7
daysafter application ofthetest maybe a
sign ofcontactsensitization.(3)
Excitedskin syndrome (angryback)isa
stateofhyperactivityinducedbydermatitis
on otherpartsofthe bodyorbya strong
positive skin-test reaction. Therefore, test
resultsshould beevaluated carefullyin
patientswith multiple, positive, concomitant
patch test results. To determine which reactions
are false-positive, re-testingat alater
datemaybe necessary. (4)
Apotentialcarcinogenicriskexistswith
nickelsulphate, potassiumdichromate,
cobalt chloride, epoxyresinandthiuram
mix.
However, due to thelow content ofallergen
andbriefcontact period (48 hours), there is
no reason tosuspect that a carcinogenic
riskexistswith TRUE Test
.
PRECAUTIONS
General:
TRUETest
TM maybe administered throughout
the year. However, in summertime
excessive sweating and exposure ofthetest
site tothesun are tobe avoided.
TRUETest
TM should beapplied onlyto
healthyskin that isfree ofacne, scars, dermatitis,
or anyothercondition that may
interfere with test results.
Since steroidsmaysuppressa positive test
reaction, use oftopicalsteroidson the test
site or oralsteroids(equivalent to10 mg
prednisolone) should bediscontinuedfor at
least two weeksprior to testing.
Ifa severe patch test reaction develops, the
patient maybe treated with atopicalcorticosteroid
preparation or, in rare cases, a
systemiccorticosteroid.
Pregnancyandpediatricuse:
The test isnotrecommended tobe applied
to the skin ofpregnant and breast-feeding
women norchildren.
ADVERSEREACTIONS
General:
Aflare-up ofdermatitismaybe observed
when testing during anactive phase ofdermatitis.
Sensitization (see warnings).
Local:
Apositive test reaction usuallydisappears
within 1-2 weeks. On rare occasions, test
reactionsmaypersist for a month, leaving
an area oftransient hypopigmentation. Irritation
caused bythesurgicaltapeadhesive
mayoccur, but usuallydisappearsrapidly.
DOSAGEANDADMINISTRATION
Dosage:
Adosagelevelfor each allergenhasbeen
establishedwhich ishigh enoughto evoke a
reaction even in weaklysensitized patients,
yet low enoughtominimize the riskofirritant
reaction.
Administration:
See under Application Instructions(also
available onthebackofeach TRUE Test
package).
Interpretation:
The reaction should bereadat 72-96 hours.
Ifa reading at 48hoursisconsidered, this
evaluation must becompleted with areading
at 72-96hoursafter test application,
when allergicreactionsare fullydeveloped
andmild irritantreactionshave faded.
Neomycin sulphate and p-phenylenediamine,
however, sometimescause reactions
which maynotappearuntil4-5 daysafter
the application.Patientsshould beinstructed
to report this. Ifappropriate,an additional
office visit willverifya late reaction.
An identification template isprovidedwith
each packageofTRUETest
TM for quickidentification
ofanyallergen whichcausesa
reaction.
Toassure correct positioning, markson the
skinshould correlate with thenotcheson
the template.
The interpretation method recommended by
the InternationalContact DermatitisResearch
Groupandthe North American Contact
DermatitisGroupis:
? Doubtfulreaction,faint macular
erythema only
+ Weak(nonvesicular)positive
reaction
-erythema
-infiltration
-possible papules
++ Strong(vesicular)positive reaction
-erythema
-infiltration
-papules
-vesicles
+++Extreme positive reaction
- bullousreaction
-
– Negative reaction
–
IR Irritantreaction ofdifferent types
NT Nottested
Note:
Patientsshowing anegative reaction may
stillbe allergicto other substancesnot
includedin these test panels. Re-testing
or testing with complementarysubstances
maybe indicated.
Apositive test reaction should meet the
criteria for an allergicreaction (papular or
vesicular erythema and infiltration)
.
Pustules, aswellaspatchyfollicular or
homogeneouserythema withoutinfiltration
are usuallysignsofirritationanddo
not indicate allergy.
False-negative resultsmayoccur.
What isimportant in evaluating apositive
test response isnotthe number of pluses
assignedto the test response, but thedetermination
of whether the response isa truly
positive reaction (caused byallergy)or a
non-specificirritantreaction.
STORAGE:
Store TRUETest
TM at 2-8°C. The expiry
dateisstatedon the package.
APPLICATION INSTRUCTIONS
1)Peelopen thepackageand remove the
test panel.
2)Remove theprotective plasticcovering
fromthetest surface ofthe panel. Be careful
not to touch the test substances.
3)Positionthe testsnext to the midline on
the patient’sbackso thatallergen Nos. 1
and 13 point to the upperleft corner.
Fromthecentre ofthepanel, smoothoutward
toward the edges, makingsure each
allergen makesadequate contact with the
skin.
4)With amedicalmarking pen, indicate the
location ofthetwo notcheson each panel.
The test should beappliedto healthyskin
thatisfree ofacne, scars,dermatitisor any
othercondition that might interfere with
interpretation ofresults(see Precautions).
The test isbest applied ontheupperpart of
the back.
However, the outer part oftheupperarmsis
also acceptable.
The patient should wear TRUETest
TM for a
minimumof48 hourswithout removing it
and be carefulnot to wet the test area.
Following thisperiod, the test isremoved,
either bythephysician orpatient.
REFERENCES
1. Roitt I, BrostoffJ, Male D: Immunology,
ed 1. St. Louis, Toronto,CWMosbyCo,
1985, chapter 22, pp 1-10.
2. CalnanC.D.: The use and abuse ofpatch
test, in Maibach HI, GellinGA(eds):
OccupationalandIndustrialDermatology,
ChicagoYear BookMedicalPublishers,
Inc. 1982, p35.
3. Fisher A:ContactDermatitis, ed3,
Philadelphia, Lea &Febiger, 1986, pp 14-
15.
4. BruynzeelDP, Maibach HI: ExcitedSkin
Syndrome (AngryBack). Arch Dermatol
122:1986, pp 323-328.
License Holder:
Gamida Ltd.
Amargad Bldg.
32, HashahamSt.
Kiryat Matalon P.O.B. 7804
Petach-Tikva 49170
Tel 972 3 9277222
Fax 9723 9277223
Manufactured by:
SMARTPRACTICEDENMARKApSHillerød, Denmark